Pathway Category Top Level |
Pathway Category Second Level |
Pathway ID |
Pathway Name |
p-Value |
Adjusted p-Value |
Enriched Genes |
09100 Metabolism |
09103 Lipid metabolism |
hsa00591 |
Linoleic acid metabolism |
4.487E-07 |
5.295E-05 |
CYP2C9, CYP3A4, CYP2C19 |
09100 Metabolism |
09111 Xenobiotics biodegradation and metabolism |
hsa00982 |
Drug metabolism - cytochrome P450 |
6.357E-06 |
3.751E-04 |
CYP2C9, CYP3A4, CYP2C19 |
09150 Organismal Systems |
09156 Nervous system |
hsa04726 |
Serotonergic synapse |
2.730E-05 |
8.054E-04 |
CYP2C9, MAPK1, CYP2C19 |
09160 Human Diseases |
09161 Cancers |
hsa05204 |
Chemical carcinogenesis |
1.070E-05 |
4.210E-04 |
CYP2C9, CYP3A4, CYP2C19 |
09130 Environmental Information Processing |
09132 Signal transduction |
hsa04010 |
MAPK signaling pathway |
3.133E-04 |
5.182E-03 |
MAPK1, MAPT, NFKB1 |
09160 Human Diseases |
09161 Cancers |
hsa05221 |
Acute myeloid leukemia |
4.317E-04 |
5.182E-03 |
MAPK1, NFKB1 |
09100 Metabolism |
09103 Lipid metabolism |
hsa00590 |
Arachidonic acid metabolism |
5.108E-04 |
5.182E-03 |
CYP2C9, CYP2C19 |
09150 Organismal Systems |
09151 Immune system |
hsa04621 |
NOD-like receptor signaling pathway |
4.317E-04 |
5.182E-03 |
MAPK1, NFKB1 |
09160 Human Diseases |
09161 Cancers |
hsa05212 |
Pancreatic cancer |
5.787E-04 |
5.182E-03 |
MAPK1, NFKB1 |
09150 Organismal Systems |
09152 Endocrine system |
hsa04917 |
Prolactin signaling pathway |
6.883E-04 |
5.182E-03 |
MAPK1, NFKB1 |
09100 Metabolism |
09108 Metabolism of cofactors and vitamins |
hsa00830 |
Retinol metabolism |
5.613E-04 |
5.182E-03 |
CYP2C9, CYP3A4 |
09160 Human Diseases |
09161 Cancers |
hsa05220 |
Chronic myeloid leukemia |
7.075E-04 |
5.182E-03 |
MAPK1, NFKB1 |
09150 Organismal Systems |
09151 Immune system |
hsa04662 |
B cell receptor signaling pathway |
7.075E-04 |
5.182E-03 |
MAPK1, NFKB1 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05131 |
Shigellosis |
5.613E-04 |
5.182E-03 |
MAPK1, NFKB1 |
09100 Metabolism |
09111 Xenobiotics biodegradation and metabolism |
hsa00980 |
Metabolism of xenobiotics by cytochrome P450 |
7.075E-04 |
5.182E-03 |
CYP2C9, CYP3A4 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05140 |
Leishmaniasis |
7.075E-04 |
5.182E-03 |
MAPK1, NFKB1 |
09160 Human Diseases |
09166 Endocrine and metabolic diseases |
hsa04933 |
AGE-RAGE signaling pathway in diabetic complications |
1.348E-03 |
7.294E-03 |
MAPK1, NFKB1 |
09160 Human Diseases |
09161 Cancers |
hsa05215 |
Prostate cancer |
1.049E-03 |
6.516E-03 |
MAPK1, NFKB1 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05133 |
Pertussis |
7.466E-04 |
5.182E-03 |
MAPK1, NFKB1 |
09130 Environmental Information Processing |
09132 Signal transduction |
hsa04066 |
HIF-1 signaling pathway |
1.402E-03 |
7.294E-03 |
MAPK1, NFKB1 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05132 |
Salmonella infection |
9.802E-04 |
6.425E-03 |
MAPK1, NFKB1 |
09150 Organismal Systems |
09151 Immune system |
hsa04660 |
T cell receptor signaling pathway |
1.429E-03 |
7.294E-03 |
MAPK1, NFKB1 |
09150 Organismal Systems |
09151 Immune system |
hsa04620 |
Toll-like receptor signaling pathway |
1.483E-03 |
7.294E-03 |
MAPK1, NFKB1 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05142 |
Chagas disease (American trypanosomiasis) |
1.429E-03 |
7.294E-03 |
MAPK1, NFKB1 |
09130 Environmental Information Processing |
09132 Signal transduction |
hsa04668 |
TNF signaling pathway |
1.596E-03 |
7.534E-03 |
MAPK1, NFKB1 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05145 |
Toxoplasmosis |
1.833E-03 |
7.987E-03 |
MAPK1, NFKB1 |
09150 Organismal Systems |
09156 Nervous system |
hsa04722 |
Neurotrophin signaling pathway |
1.895E-03 |
7.987E-03 |
MAPK1, NFKB1 |
09140 Cellular Processes |
09143 Cell growth and death |
hsa04210 |
Apoptosis |
2.567E-03 |
9.772E-03 |
MAPK1, NFKB1 |
09150 Organismal Systems |
09158 Development |
hsa04380 |
Osteoclast differentiation |
2.287E-03 |
9.129E-03 |
MAPK1, NFKB1 |
09130 Environmental Information Processing |
09132 Signal transduction |
hsa04071 |
Sphingolipid signaling pathway |
1.895E-03 |
7.987E-03 |
MAPK1, NFKB1 |
09160 Human Diseases |
09167 Infectious diseases |
hsa05160 |
Hepatitis C |
2.321E-03 |
9.129E-03 |
MAPK1, NFKB1 |